Tidal Investments’s BeOne Medicines Ltd ONC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$3.86M Buy
13,561
+928
+7% +$273K 0.01% 1040
2026
Q1
$3.75M Buy
12,633
+11,725
+1,291% +$3.8M 0.01% 909
2025
Q4
$276K Buy
908
+69
+8% +$22.6K ﹤0.01% 1884
2025
Q3
$286K Buy
+839
New +$255K ﹤0.01% 1841

Other funds holding ONC

Tidal Investments's ONC Position: Q2 2026 in Review

Tidal Investments increased its BeOne Medicines Ltd (ONC) stake by 7.3% in Q2 2026, buying an estimated $273K and bringing the position to 13,561 shares worth $3.86M. The position accounts for 0.01% of the portfolio, ranked #1040.

Tidal Investments first reported a position in ONC in Q3 2025 and has held it in 4 quarters since. 283 funds tracked by Wall St. Rank hold ONC as of Q2 2026.

  • Tidal Investments held 13,561 shares of BeOne Medicines Ltd worth $3.86M as of Q2 2026.
  • Tidal Investments bought 928 BeOne Medicines Ltd shares in Q2 2026, an estimated $273K.
  • BeOne Medicines Ltd made up 0.01% of Tidal Investments's portfolio in Q2 2026, its #1040 holding.
  • Tidal Investments first reported a position in BeOne Medicines Ltd in Q3 2025 and has held it in 4 quarters since.
  • 283 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q2 2026.

Based on Tidal Investments's 13F filing for Q2 2026, filed 13 Aug 2026.